Sankey It
Loading...
Johnson & Johnson FY2025 income statement | Sankey It
Sankey It · JNJ
Johnson & Johnson FY2025 income statement
USD · fiscal year ended 2025-12-28
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Johnson & Johnson FY2025 income statement
Flow diagram with 9 nodes and 8 flows for Johnson & Johnson FY2025 income statement. Values: Innovative Medicine US$60.4B, MedTech US$33.8B, Revenue US$94.2B, Cost of Revenue US$25.6B, Gross Profit US$68.6B, Operating Expenses US$43B, Operating Income US$25.6B, Tax US$5.8B, Net Income US$26.8B.
Innovative Medicine
US$60.4B
+6% Y/Y
64% of revenue
MedTech
US$33.8B
+6% Y/Y
36% of revenue
Revenue
US$94.2B
+6% Y/Y
Cost of Revenue
(US$25.6B)
-7% Y/Y
27% of revenue
Gross Profit
US$68.6B
+12% Y/Y
73% margin
Operating Expenses
(US$43B)
+10% Y/Y
46% of revenue
Operating Income
US$25.6B
+16% Y/Y
27% margin
Tax
(US$5.8B)
+120% Y/Y
6% of revenue
Net Income
US$26.8B
+91% Y/Y
28% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen